Savella



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Fibromyalgia 83.6%
Pain 4.6%
Depression 2.5%
Neuralgia 1.3%
Neuropathy Peripheral 1.3%
Back Pain 1.0%
Asthma 0.7%
Insomnia 0.7%
Arthralgia 0.6%
Migraine 0.6%
Myofascial Pain Syndrome 0.5%
Anxiety 0.5%
Complex Regional Pain Syndrome 0.4%
Headache 0.3%
Hypertension 0.3%
Blood Cholesterol Increased 0.2%
Gastric Bypass 0.2%
Myalgia 0.2%
Osteoarthritis 0.2%
Pain In Extremity 0.2%
Nausea 14.1%
Suicidal Ideation 10.0%
Vomiting 9.9%
Rash 6.2%
Headache 5.7%
Hyperhidrosis 5.6%
Palpitations 5.3%
Insomnia 5.2%
Tremor 4.4%
Serotonin Syndrome 4.3%
Blood Pressure Increased 4.1%
Urinary Retention 3.4%
Vision Blurred 3.4%
Dizziness 3.2%
Pain 3.2%
Tachycardia 2.7%
Feeling Abnormal 2.4%
Pruritus 2.3%
Hot Flush 2.2%
Weight Decreased 2.2%
Secondary
Fibromyalgia 65.6%
Pain 6.2%
Asthma 4.2%
Depression 3.9%
Migraine 2.4%
Hypertension 2.0%
Insomnia 1.9%
Neuralgia 1.5%
Seasonal Allergy 1.4%
Blood Cholesterol Increased 1.3%
Anxiety 1.3%
Arthralgia 1.1%
Drug Use For Unknown Indication 1.1%
Back Pain 1.0%
Product Used For Unknown Indication 1.0%
Gastrooesophageal Reflux Disease 1.0%
Neuropathy Peripheral 1.0%
Arthritis 0.8%
Intervertebral Disc Protrusion 0.6%
Myofascial Pain Syndrome 0.6%
Vomiting 11.4%
Nausea 10.3%
Suicidal Ideation 9.8%
Hyperhidrosis 6.1%
Tremor 5.6%
Serotonin Syndrome 4.9%
Suicide Attempt 4.7%
Palpitations 4.4%
Sinusitis 4.4%
Rash 4.2%
Vision Blurred 4.2%
Mental Status Changes 4.0%
Blood Pressure Increased 3.7%
Insomnia 3.7%
Drug Hypersensitivity 3.5%
Headache 3.5%
Hot Flush 3.0%
Pain 3.0%
Vertigo 3.0%
Migraine 2.6%
Concomitant
Product Used For Unknown Indication 35.3%
Fibromyalgia 13.5%
Pain 10.1%
Rheumatoid Arthritis 7.9%
Depression 4.5%
Gastrooesophageal Reflux Disease 3.4%
Anxiety 3.0%
Hypertension 2.9%
Insomnia 2.5%
Migraine 1.8%
Crohn's Disease 1.8%
Nausea 1.7%
Sleep Disorder 1.7%
Arthritis 1.6%
Blood Cholesterol Increased 1.5%
Back Pain 1.4%
Hypothyroidism 1.4%
Asthma 1.3%
Muscle Spasms 1.3%
Multiple Sclerosis 1.3%
Pain 9.6%
Wrong Technique In Drug Usage Process 9.1%
Headache 8.7%
Drug Ineffective 7.3%
Vomiting 6.4%
Nausea 5.9%
Pain In Extremity 5.0%
Weight Decreased 5.0%
Fatigue 4.6%
Weight Increased 4.6%
Injection Site Pain 4.1%
Rash 3.7%
Walking Aid User 3.7%
Depression 3.2%
Drug Withdrawal Syndrome 3.2%
Myalgia 3.2%
Off Label Use 3.2%
Product Quality Issue 3.2%
Swelling 3.2%
Urinary Tract Infection 3.2%
Interacting
Fibromyalgia 75.0%
Depression 12.5%
Migraine 12.5%
Weight Decreased 71.4%
Activities Of Daily Living Impaired 14.3%
Headache 14.3%